Related references
Note: Only part of the references are listed.Castration-Refractory Prostate Cancer: New Drugs in the Pipeline
Dirk Schrijvers et al.
ADVANCES IN THERAPY (2010)
Targeted therapeutic approaches for hormone-refractory prostate cancer
Flora Stavridi et al.
CANCER TREATMENT REVIEWS (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Ellen A. M. Schenk
EUROPEAN UROLOGY (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Sipuleucel-T
Celestia S. Higano et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
Tao Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
Paolo Gandellini et al.
CANCER RESEARCH (2009)
Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
Qiong Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Dietary agents for chemoprevention of prostate cancer
Deeba N. Syed et al.
CANCER LETTERS (2008)
TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche
Masayoshi Yamamoto et al.
CANCER RESEARCH (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
microRNAs and prostate cancer
Xu-Bao Shi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells
Alla Musiyenko et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism
Matthew B. Rettig et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
The mechanism by which molecules containing the HIV-1 gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation
Jing-He Huang et al.
BIOCHEMICAL JOURNAL (2007)
Hyaluronan stimulates transformation of androgen-independent prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2007)
MicroRNA and cancer: Current status and prospective
Wei Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
IL-12p40: an inherently agonistic cytokine
Andrea M. Cooper et al.
TRENDS IN IMMUNOLOGY (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Expression of CCL5 (RANTES) and CCR5 in prostate cancer
GG Vaday et al.
PROSTATE (2006)
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Ron N. Apte et al.
CANCER AND METASTASIS REVIEWS (2006)
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
A Malik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interieukin-6 regulation of prostate cancer cell growth
Z Culig et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
The molecular requirements for cytokinesis
M Glotzer
SCIENCE (2005)
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
EP Lansky et al.
INVESTIGATIONAL NEW DRUGS (2005)
Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells
M Albrecht et al.
JOURNAL OF MEDICINAL FOOD (2004)
Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18
AL Omara-Opyene et al.
LABORATORY INVESTIGATION (2004)
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6
H Steiner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Involvement of large tenascin-C splice variants in breast cancer progression
T Tsunoda et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway
H Steiner et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation
HS Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Cross-talk unfolded:: MARCKS proteins
A Arbuzova et al.
BIOCHEMICAL JOURNAL (2002)
Timeline - Matrix metalloproteinases: a tail of a frog that became a prince
CE Brinckerhoff et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Role of eicosanoids in prostate cancer progression
DT Nie et al.
CANCER AND METASTASIS REVIEWS (2001)
Vertebrate tropomyosin: distribution, properties and function
SV Perry
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2001)
Share Paper
